|
| 2011～2013年武汉地区32家医院β-内酰胺复方制剂用药分析 |
| Application Analysis of β-lactam Compound Preparation in 32 Hospitals in Wuhan Area during 2011-2013 |
| |
| DOI： |
| 中文关键词: β-内酰胺复方制剂 用药金额 用药频度 日均费用 |
| 英文关键词:β-lactam compound preparation Consumption sum DDDs DDC |
| 基金项目: |
|
| 摘要点击次数: 843 |
| 全文下载次数: 1062 |
| 中文摘要: |
| 摘 要 目的:了解抗菌药物专项整治活动期间武汉地区β-内酰胺复方制剂用药情况，为合理用药提供依据。方法：统计分析2011～2013年武汉地区32家医院β-内酰胺复方制剂的用药金额、用药频度和日均费用。结果：2011～2013年武汉地区32家医院β-内酰胺复方制剂的用药金额呈逐年增长趋势，特别是头孢菌素/酶抑制药的增长更为显著。三年中用药金额最高的药物是头孢哌酮/他唑巴坦，用药频度最高的是羟氨苄青霉素/克拉维酸钾。结论：通过抗菌药物专项整治活动，β-内酰胺复方制剂的品种、品规数得到控制，但用药量仍呈显著增长趋势。为了促进β-内酰胺复方制剂的合理应用，除了加强管理，还应充分发挥国家细菌耐药监测网的指导作用。 |
| 英文摘要: |
| ABSTRACT Objective:To investigate the application of β-lactam compound preparations in Wuhan area in the period of special rectification activities of antimicrobial agents so as to provide reference for rational use of antibiotics. Methods:The utilization of β-lactam compound preparations during 2011-2013 in Wuhan were analyzed retrospectively in terms of consumption sum, DDDs and DDC. Results:The consumption sum and DDDs of β-lactam compound preparations have increased year by year during 2011-2013. Cephalosporin/enzyme inhibitors were the most significant part of the growth. Cefoperazone /tazobactam and amoxicillin/clavulanate took the first place of consumption sum and DDDs respectively over the past 3 years. Conclusion:The variety and specifications of β-lactam compound preparations are under control through the period of special rectification activities of antimicrobial agents, but the utilization of the compound preparations increase remarkably. It is necessary to enhance the management of such preparations and give full play of the CHINET platform for the rational use of β-lactam compound preparations. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
